Abbott Reports Strong Sales and Earnings Growth in Third Quarter
- Details
- Category: Abbott
![Abbott Abbott](http://www.worldpharmanews.com/images/stories/logo/abbott.gif)
- Diluted earnings per share, excluding specified items, were $0.79, above Abbott's previously announced guidance range of $0.76 - $0.78, reflecting 17.9 percent growth.
GSK responds to NICE's second technology appraisal consultation document on the use of Tyverb
- Details
- Category: GlaxoSmithKline
![GlaxoSmithKline GlaxoSmithKline](http://www.worldpharmanews.com/images/stories/logo/gsk.gif)
European Journalists' Prize 2008 announced by Bayer HealthCare
- Details
- Category: Bayer
![Bayer AG Bayer AG](http://www.worldpharmanews.com/images/stories/logo/bayer.gif)
Early data show potential for imatinib to treat life-threatening form of pulmonary artery disease
- Details
- Category: Novartis
![Novartis Novartis](http://www.worldpharmanews.com/images/stories/logo/novartis_b.gif)
Genzyme Recognized by Scientists as a Top Employer
- Details
- Category: Genzyme
![Genzyme Corporation Genzyme Corporation](http://www.worldpharmanews.com/images/stories/logo/genzyme.gif)
ERS COPD Research Award 2008 sponsored by Boehringer Ingelheim
- Details
- Category: Boehringer Ingelheim
![Boehringer Ingelheim Boehringer Ingelheim](http://www.worldpharmanews.com/images/stories/logo/boehringeringelheim.gif)
Novo Nordisk and Innate Pharma swap product rights
- Details
- Category: Novo Nordisk
![Novo Nordisk A/S Novo Nordisk A/S](http://www.worldpharmanews.com/images/stories/logo/novonordisk_b.gif)
More Pharma News ...
- Bayer Reports Progress in Clinical Program for Riociguat
- Boehringer Ingelheim signs a license agreement with Evec Inc. for its fully-human antibody programme
- Roche invests 215 million Swiss francs in diagnostics facility at Penzberg
- Shire Limited has changed its name to Shire plc
- Bayer starts new research cooperation in Asia
- Data from one-year liraglutide phase 3 study published in The Lancet
- US Court Denies Teva's Motion For Summary Judgment In Pulmicort Respules Patent Litigation